Twist Bioscience (TWST) Growth Rates Comparisons to Biotechnology & Pharmaceuticals Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Industry, else..
 
Twist Bioscience Corporation  (NASDAQ: TWST)
 

Twist Bioscience Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TWST Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 23.24 % 5.15 % 9.19 % 10.9 %
Q / Q Revenue Growth (Q2 MRQ) 6.92 % -11.92 % -3.28 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 19.19 % 5.66 % 7.99 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) 5.45 % 1.16 % 2.09 % 2.61 %
Revenue 5 Year Average Growth 33.11 % 8.2 % 8.65 % 10.59 %


TWST's Growth Comparisons in III. Quarter 2026




With 23.24% year on year Revenue increase in the third quarter 2026, Twist Bioscience outperformed the 5.15% growth in the Biotechnology & Pharmaceuticals industry, and 9.19% growth in the Healthcare sector. Despite modest Sales rises in the Healthcare sector and in the Biotechnology & Pharmaceuticals industry, Twist Bioscience Corporation reported above average market Sales growth.

Comparing the company's Revenue to the second quarter results, sales were higher by 6.92% . On the yearly basis, average annual sales growth for Twist Bioscience is 33.11%, while S & P 500's including only Businesses with the third quarter 2026 earnings, average annual sales growth is 10.59% over the past five years.

TWST Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Americas
236.68 %
210.93 %
EMEA
255.65 %
192.75 %
Asia Pacific
-
-
Antibody discovery
2766.14 %
-
NGS tools
210.91 %
-
Reportable
-
-
Total
23.24 %
6.92 %


Growth Rates of TWST's Income in the third quarter 2026


TWST Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) - 440.27 % 5.13 % 97.6 %
Sequential Operating Income Change (Q2 MRQ) - -48.89 % 0.89 % 48.13 %
Y / Y Operating Income Growth (Q2 TTM) - 1001.37 % 30.96 % 40.67 %
Sequential Operating Income Growth (Q2 TTM) - 230.11 % 4.91 % 20.86 %
Operating Income 5 Year Avg. Change - -18.41 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) - -78.96 % -25.81 % 90.69 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) - - -66.16 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) - -86.62 % 9.85 % 57.33 %
Sequential Income from Cont. Ops. Change (Q2 TTM) - -59.12 % -4.69 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change - -11.5 % 0.17 % -28.52 %

TWST Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) - -79.71 % -26.29 % 90.69 %
Q / Q Net Income Growth (Q2 MRQ) - -87.33 % -0.86 % 27.07 %
Y / Y Net Income Change (Q2 TTM) - 103.17 % 15.48 % 57.33 %
Sequential Net Income Change (Q2 TTM) - -7.85 % -6.71 % 18.65 %
Net Income 5 Year Avg. Growth - -8.55 % 9.21 % 22.96 %

TWST's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) - -82.2 % -25.81 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) - - -66.16 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) - - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth - 49.32 % 0.17 % -28.52 %



TWST EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) - -82.83 % -26.29 % -28.52 %
Q / Q EPS Net Growth (Q2 MRQ) - -88.8 % -0.86 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) - - -4.12 % 4.93 %
EPS Net 5 Year Avg. Change - -8.55 % 9.21 % 22.96 %



Twist Bioscience reported bottom-line of $ -0.56 in the third quarter, compare to $ 0.33 in the same quarter a year ago. Biotechnology & Pharmaceuticals industry fell by -82.83%, while Healthcare sector decreased by -26.29%, and overall market improved by 90.69%.

Comparing company's EPS to the second quarter results, income per share were higher by 6.92% . On the yearly basis, average annual income per share growth for Twist Bioscience is 33.11%, while S & P 500's including only the businesses with the third quarter 2026 Results, average annual income per share growth is 22.96% over the past five years.

TWST Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) - 6160.46 % 48.48 % 48.62 %
Sequential Free Cash Flow Change (Q2 MRQ) - -53.57 % -46.96 % 34.18 %
Y / Y Free Cash Flow Change (Q2 TTM) - 14.3 % 19.59 % 60.27 %
Sequential Free Cash Flow Change (Q2 TTM) - 17.12 % 5.76 % 15.75 %
Free Cash Flow 5 Year Avg. Change - -14.51 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q2 MRQ) - 36.63 % - 216.68 %
Y / Y Net Cash Flow Change (Q2 TTM) - 781.29 % - 209.43 %
Sequential Net Cash Flow Change (Q2 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change - 23.25 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) 6.52 % 32.26 % 8.23 % 120.03 %
Sequential Capital Expenditures Change (Q2 MRQ) -24.82 % -1.95 % -22.09 % 36.87 %
Y / Y Capital Expenditures Change (Q2 TTM) 156.85 % -4.97 % 7.77 % 109.38 %
Sequential Capital Expenditures Change (Q2 TTM) 1.34 % 7.49 % 1.52 % 23.05 %
Capital Expenditures 5 Year Avg. Change 23.2 % 9.64 % 8.61 % 14.74 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.